Questions answered

Each patient is assessed individually. Medical history, cancer type, stage, overall health, and personal goals are considered before supportive options are outlined.

Yes. Integrative approaches can complement conventional treatments and serve as adjunctive therapy. Our doctors review any previous or existing care so the plan takes it into account and works alongside it.

Patients seek integrative support at many different stages of their cancer journey, including prevention. Care plans are tailored to individual circumstances: diagnosis, stage, any current treatments, and overall wellbeing.

Lymphatic Therapy is used to support cancer treatment, rather than replace primary cancer treatment.

No, but our medical team will determine the best treatments for you and your individual case.

It can cause fewer or less severe side effects, but this is not guaranteed as toxicity depends on the specific drug, dose, schedule and individual patient. Metronomic chemotherapy should therefore not be regarded as "side-effect free" chemotherapy but we have found it a lot better tolerated by hundreds of our patients over the years.

Colonic Therapy involves flushing the colon with water or a saline solution to assist with the removal of waste.

Our HBOT machines deliver oxygen at 2.0 ATA.

As all of our treatment programmes are built around you as an individual, we will need to see your medical records and your current diagnosis to determine how we can support you, but it’s likely we will be able to support in some way.

No. Most pancreatic cancers arise in cells involved in digestion and are adenocarcinomas. Pancreatic neuroendocrine tumours arise in hormone-producing cells and are assessed and treated differently.

Source: National Cancer Institute

No. They begin in different types of cells. Pancreatic neuroendocrine tumours have their own assessment and treatment pathways, so information about the more common pancreatic adenocarcinoma may not apply.

Sources: National Cancer Institute; National Cancer Institute

Yes. All of our cancer programs at Verita Life are designed to fit around existing treatments. Our Doctors will give you specific advice based on your current or planned treatments as part of your initial consultations through to your aftercare program.

Yes, our therapies and treatments are designed to work in conjunction with conventional approaches rather than replacing them. The best advice we can give is to book a free consultation with one of our Doctors, as this will give you a second opinion and mean you can act fast and support your overall wellbeing and immune system whatever route you decide to take.

Yes, patients can explore integrative support after surgery, hormone-based treatment, and conventional cancer treatment as part of recovery and managing health moving forward.

A change in a mole is a reason for medical assessment, but appearance alone does not confirm melanoma. Examination and a biopsy, when indicated, allow tissue to be checked for cancer.

Source: National Cancer Institute

Yes. A benign tumour is not cancer, but it can press on brain tissue and affect how that area works. Its location and effects still need specialist assessment.

Source: National Cancer Institute

Each case depends on the individual, but after a full assessment of your health and clinical assessment if we can help, we will.

Yes, many Verita Life patients can better manage side effects like fatigue and discomfort after integrative care.

While a referral isn’t required, we will need access to your medical history and diagnosis to understand whether or not supportive care is appropriate for you.

Yes, we have treated many patients with both colon and rectal cancer at every stage. You can find out more on the Patient stories page or reach out to our team for more information.

No. Treatment is specific to the blood cancer subtype and the person’s circumstances. A plan for leukaemia cannot simply be applied to lymphoma or myeloma for example - during your consultation our doctor will explain which approach will guide your treatment.

No. Functioning tumours release hormones that can cause symptoms, while non-functioning tumours do not cause a hormone-related syndrome. Non-functioning tumours can still cause symptoms as they grow.

Source: National Cancer Institute

No. Surgery, radiotherapy, or drug treatment are normally considered in different combinations in conventional medicine, while our approach depends on where the cancer began, its stage and the person’s general health.

Source: National Cancer Institute

At Verita Life we support patients with a range of different breast cancer types including hormone receptor-positive, HER2-positive, triple-negative, invasive and non-invasive breast cancers, as well as less common forms of breast cancer such as inflammatory or lobular breast cancers.

We treat patients at every stage of their diagnosis, including those who have been recently diagnosed and those seeking additional support after treatment.

No. Most thyroid nodules are not cancer. Assessment may involve ultrasound, blood tests, and a fine-needle biopsy, depending on the findings. A lump needs proper assessment rather than an assumption that it is cancer.

Source: National Cancer Institute

No. HPV infection is common and often clears on its own. Persistent infection with certain high-risk HPV types can cause changes that may lead to cervical cancer. An HPV result by itself is not a cancer diagnosis.

Source: National Cancer Institute

There is no one-size-fits all approach at Verita Life, and as well as all our treatment plans being created for individual cases they are fully adaptable based on changes in the patient’s condition.

A primary brain tumour begins in the brain. A brain metastasis is cancer that began elsewhere and spread to the brain.

Source: National Cancer Institute

A clinician examines the skin and may take a biopsy. A pathologist checks the sample to establish whether cancer is present and identify its type. A new or changing skin lesion should be assessed rather than diagnosed from appearance alone.

Source: National Cancer Institute

Melanoma develops in pigment-producing cells called melanocytes. It is less common than basal cell and squamous cell skin cancers, but has a greater tendency to spread. The specific diagnosis affects how it is assessed and treated.

Sources: National Cancer Institute; National Cancer Institute

Every patient at Verita Life will receive a fully customised program, catering for the patient's unique diagnosis, current stage, and future goals.

No. Hepatocellular carcinoma begins in liver cells. Cholangiocarcinoma begins in bile duct cells and can occur inside or outside the liver. They are different diagnoses with different treatment pathways.

Sources: National Cancer Institute; National Cancer Institute

No. Primary liver cancer starts in the liver. Cancer that reaches the liver from another organ remains a cancer of its original site, and the treatment discussion needs to reflect that origin.

Source: National Cancer Institute

No. Endometrial cancer begins in the lining inside the uterus. Cervical cancer begins in the cervix. Uterine sarcoma is another distinct cancer involving the muscle or supporting tissues of the uterus.

Sources: National Cancer Institute; National Cancer Institute

Many of our patients at Verita Life choose integrative support after completing conventional treatment, such as immune support therapies, wellness and diet education, oxygen therapy, or organ support.

Yes. All of our treatment plans address symptom support as well as addressing the cancer directly where possible. During the consultation and onboarding process, our team will explain which treatments are suggested for which reasons and you can make the decision based on your goals and what you are comfortable with.

The plan depends on how far the cancer has developed, your overall health, and your preferences. Your care team should explain the goals, possible side effects, and expected course of each proposed treatment.

Source: National Cancer Institute

The extent of the cancer and your age and general health help guide treatment.

Source: National Cancer Institute

The team considers the cancer’s type, stage, and grade, whether surgery can remove it, and your overall health. Previous treatment and findings such as BRCA gene changes may also affect the options.

Source: National Cancer Institute

The cancer type, the lesion’s size and location, and your general health influence the options. For squamous cell carcinoma, the stage also matters. Your specialist can explain the choice for the particular lesion.

Source: National Cancer Institute

Our expert team will review your medical history, current and previous treatments and any other concerns you might have. With this information we can determine whether or not integrative support is appropriate and which of our therapies could be considered.

These terms describe how a leukaemia develops. Acute leukaemias generally progress quickly, while chronic forms usually develop more slowly. The cell type and other test findings also affect the diagnosis and care plan.

Source: National Cancer Institute

Hepatobiliary cancers involve the liver, bile ducts, or gallbladder. They are a group of different diagnoses rather than one cancer, so the organ and cell type where the disease began need to be identified.

Sources: Verita Life cancer guide; National Cancer Institute; National Cancer Institute

Muscle-invasive disease has grown into the bladder muscle. Non-muscle-invasive disease has not reached that layer. This distinction is important when the specialist discusses treatment options.

Source: National Cancer Institute

The term commonly refers to basal cell carcinoma and squamous cell carcinoma of the skin. Melanoma is a different skin cancer. A pathology diagnosis helps distinguish these conditions.

Source: National Cancer Institute

Resectable means the cancer is considered removable by surgery. The assessment looks at its location and extent, including involvement of nearby structures. Being medically fit for an operation is a separate but important consideration for any surgical team.

Source: National Cancer Institute

The team considers the tumour’s cell type, its location, its grade, and any tumour remaining after surgery. Adult primary brain tumours do not use the same standard staging system as many other cancers.

Source: National Cancer Institute

Renal cell carcinoma is the most common kidney cancer in adults. It begins in cells lining the kidney’s small tubules. Other cancers can also affect the kidney, so the diagnosis should name the specific type.

Source: National Cancer Institute

One of the key things we offer is around nutrition, which is important in supporting the immune system. Three meals per day (plus snacks) are provided to all patients from our on-site kitchen. We also support patients with strength, recovery and overall wellbeing as part of their overall care program. Outside of the direct care program, we also offer a wide range of support on practical and recreational topics such as arranging patient and loved ones travel, visas, accommodation, daily transport to the clinic, guidance and support on Bangkok and the surrounding areas.

Bring your pathology report and records of bladder surgery, BCG, chemotherapy, or radiotherapy. Tell the team about urinary symptoms and changes in how you pass urine.

Source: Verita Life cancer guide

Bring imaging reports, any pathology results, recent kidney-function results, and records of kidney surgery. Include a list of medicines and supplements so the team can consider them alongside your existing care.

Source: Verita Life cancer guide

Bring ultrasound and pathology reports, records of surgery or radioactive iodine treatment, and your thyroid medication list. Mention changes in swallowing, voice, or energy and explain your current specialist follow-up plan.

Source: Verita Life cancer guide

Bring the biopsy or surgical pathology report and details of previous treatment. Mention ongoing bleeding or pain, menopause symptoms, and any concerns about fertility or sexual wellbeing.

Source: Verita Life cancer guide

Bring your biopsy report, imaging, and current treatment plan. Tell the team about difficulties with eating, drinking, swallowing, voice, or dental health so these can be considered alongside specialist care.

Source: Verita Life cancer guide

Ask how the cancer’s stage, your health, and your preferences affect the plan. Discuss possible side effects and fertility concerns before treatment begins so our medical team can explain the available options.

Source: National Cancer Institute

Neuroendocrine cancers arise in cells with nerve-signalling and hormone-producing functions. They can develop in several organs, including the digestive tract, pancreas, and lungs. The starting site is part of the diagnosis.

Sources: Cancer Research UK; National Cancer Institute

Most bladder cancers begin in the urothelium, the lining on the inside of the bladder. The pathology report identifies the cell type, which helps our medical team plan your care.

Cervical cancer begins in the cervix, where the lower part of the uterus joins the vagina. The main types are squamous cell carcinoma and adenocarcinoma.

Source: National Cancer Institute

This group includes cancers of the mouth, throat, voice box, nasal cavity, sinuses, and salivary glands. The exact site and cell type are important parts of the diagnosis.

Source: National Cancer Institute

Blood cancers include leukaemias, lymphomas, and myeloma. They affect different cells and tissues: leukaemias involve blood-forming cells, lymphomas involve lymphocytes, and myeloma involves plasma cells. The exact diagnosis matters because these conditions are treated differently.

Sources: National Cancer Institute; National Cancer Institute; National Cancer Institute

Epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer arise in related tissue and are generally managed in similar ways. Other ovarian tumour types can need a different approach.

Source: National Cancer Institute

The depth of melanoma in the skin is one part of staging. Doctors also consider features such as ulceration and whether it has reached lymph nodes or other organs. The full assessment guides the treatment discussion.

Source: National Cancer Institute

Papillary, follicular, medullary, and anaplastic thyroid cancers have different characteristics and treatment pathways. The pathology report identifies the type, so a treatment used for one type may not be suitable for another.

Source: National Cancer Institute

Staging describes how far the cancer has spread within or beyond the ovaries. This information helps the specialist plan treatment and explain the diagnosis. Tests used during diagnosis may also contribute to staging.

Source: National Cancer Institute

No, although they are related. CAR-T therapy takes a patient's own T cells and genetically engineers them in a laboratory so they lock onto one specific marker on cancer cells. NK cells come from a different branch of the immune system and recognise abnormal cells with their own built-in receptors, so they can work without genetic modification. They can also come from donors without close matching and have not been linked to cytokine release syndrome or graft-versus-host disease (serious reactions sometimes seen with T-cell therapies).

No, caution and experienced medical guidance needs to be used. ‘Wellness’ peptides have surged in popularity recently but can carry risks for cancer patients as they can theoretically encourage or stimulate tumour growth.

No, certain cellular treatments such as NK Cells and Dendritic cells are types of immunotherapy but how they work differs and they all have different purposes. Part of the reason they are an exciting area for cancer treatment is the way they can be combined together. Immunotherapy is now part of conventional treatment for many types of cancer, whereas our approach to combine together with the cellular treatments is more Integrative.

Yes, hyperthermia therapies are usually used with other conventional cancer therapies because they can make the cancer cells more sensitive to this treatment.

Normally yes, though specific advice will depends on the product and the current supplementation you are taking. During our consultation and treatment plan we will offer guidance on this and encourage you to speak with any existing oncologist you are working with to ensure there are no concerns.

Unfortunately it’s not as simple as starving cancer as the cells are are ‘metabolically flexible’ and can easily adapt to consume alternative nutrients if glucose levels drop to continue multiplying. What is simple is that high-sugar diets create inflammation, which in turn can help cancer thrive, so this is important to remove - a simple way to do this is cutting out all ultra-processed foods and added sugar from your diet.

Hyperthermia may be used with radiotherapy or chemotherapy in selected circumstances. Your team should explain the evidence for the proposed combination, its risks, and how it will be coordinated with your treating oncologist. It does not replace prescribed cancer treatment.

Yes, Organ Support can be considered alongside and after chemotherapy.

Supportive therapies like detox may be considered after radiotherapy, but there is no established need to "detox" radiation from the body.

Radiotherapy works by delivering radiation to a specific area of the body. Unlike a drug, radiation itself does not remain in the body and does not need to be removed through a detoxification process once the treatment has finished.

After radiotherapy, supportive care may instead focus on helping the body recover from treatment, managing symptoms and supporting nutrition, hydration, physical function and general wellbeing. The appropriate approach depends on the area treated, the type and dose of radiotherapy and any side effects experienced.

Yes, absolutely. Supportive care can address a wide range of symptoms and practical needs alongside conventional cancer treatment. There is no single supportive treatment that is right for every patient. Our clinicians consider your cancer diagnosis, conventional treatments, medical history, current symptoms and overall health before recommending which supportive therapies may be appropriate.

No. Feeling unwell is not evidence of benefit and should be reported and assessed.

Not by itself. Ask which clinical outcomes will be monitored and how those findings would change the plan.

No. Finding a metal in a blood, urine or other test does not automatically mean that chelation is needed.

Many metals are naturally present in the body, and some (including iron, zinc and copper) are essential for normal health. Even metals that can be harmful may be detected at low levels without requiring treatment.

Whether chelation is appropriate depends on factors such as which metal has been detected, the level, the type and duration of exposure, the test used, any symptoms and the individual's overall health.

Not always. Some uses are established in clinical practice. Others have limited evidence, so ask which situation applies to the proposed medicine.

Not necessarily. Some off-label cancer prescriptions have substantial clinical support, while other uses are still being investigated. Ask about the evidence for the exact medicine and proposed use, and how it compares with established options.

Sweating is one of the body's normal physiological processes, but it is not a major route for eliminating most drugs, chemotherapy agents or other substances from the body.

The liver and kidneys play a much more important role in processing and eliminating many substances, while the lungs and gastrointestinal system also contribute to normal elimination.

Heat therapies and exercise can cause sweating and may have benefits for relaxation, circulation, physical wellbeing and recovery. However, we would not describe them as a way to "sweat out" cancer, chemotherapy or unspecified toxins.

NK cells attack abnormal cells directly and quickly, without needing to be trained. Dendritic cells don't attack cancer themselves; they teach T cells which specific markers to target. The two are sometimes considered together because they act on different parts of the immune system.

No. Our team will look into your diagnosis, medical history, and current treatments before we determine whether or not immunotherapy is suitable for you.

The external radiofrequency treatment described here does not require surgery or an incision. Applicators are placed against the skin. This is different from radiofrequency ablation, which uses an inserted probe and higher temperatures.

No. NK cells are mature immune cells taken from blood and grown in a laboratory. They are not stem cells and do not turn into other types of tissue.

No. NK cells are natural cancer-fighting immune cells found within our bodies. CAR-NK cells are NK cells that have been genetically engineered with an additional "targeting system" to recognise a particular cancer. At Verita Life, we currently only work with natural NK cells.

No, not every cancer patient will be offered whole body hyperthermia. When you arrive at Verita Life we will perform a thorough medical assessment to determine whether or not it is suitable for you.

Our approach is that cancer care should be personalised to the individual, so the answer to whether detox is required after chemo is not the same for everyone - different cancer treatments create different demands on the body as well as different side effects. Our approach to "detoxification" focuses on supporting normal physiological function and recovery rather than claiming to simply remove chemotherapy or other cancer treatments from the body.

No. Its safety needs to be assessed in the proposed dose, combination, and patient group, including possible effects on other treatment.

It is often called one, but it is a treatment vaccine, not a preventive one. It is given to people who already have cancer, with the aim of training their immune system to recognise the cancer. It does not prevent cancer in healthy people.

No, Hyperthermic Intraperitoneal Chemotherapy or HIPEC is a conventional treatment where heated chemotherapy is circulated directly around the abdominal organs to try and kill any microscopic cancer cells in the peritoneal cavity during a surgery.

Immunotherapy is not typically a single treatment, so while individual treatments such as Natural Killer Cell Therapy can ‘boost’ your immune system by adding more cancer-fighting cells to your body, other approaches help with the bodies natural antigen detection.

No, lymphatic drainage is not a deep massage. Manual Lymphatic Drainage (MLD) is an exceptionally gentle, light-touch therapy designed to stimulate fluid movement rather than manipulate muscle tissue.

No, metronomic chemotherapy and Insulin Potentiation Therapy (IPT) are not the same. While both involve using lower doses of chemotherapy than traditional high-dose regimens, metronomic does not utilise Insulin and the treatments rely on entirely different biological mechanisms and protocols.

No. Ozone is chemically different from oxygen used for breathing support or in a hyperbaric chamber. Evidence for those treatments cannot be transferred to ozone.

No, EBOO uses an extracorporeal blood circuit (similar in appearance to dialysis) but it is not kidney dialysis. Rather than filtering waste from the blood, EBOO temporarily circulates blood through a system where it is exposed to a controlled oxygen–ozone mixture before being returned to the body.

Contact our medical team immediately if you experience side effects as some can be common but also be mitigated. Explain the symptoms and their effect on your daily life so the team can discuss management or alternatives.

No, a diet needs to fit your clinical and nutritional situation. Our diet is based on keto principles but balanced, nutritious meals are our top priority for patients.

Suitability depends on more than the cancer name. The team assesses the tumour’s location and depth, previous treatment, and whether a relevant combination of treatments is supported by evidence. Studies of one hyperthermia technique or tumour setting do not establish that every patient with that cancer will benefit.

We can work with your needs - the aim is to create a practical plan for your specific situation, with additional nutritional support when appropriate.

Local body hyperthermia applies controlled heat to a selected area of the body. External applicators deliver energy through the skin. The temperature, target area, and schedule depend on the treatment technique and the individual care plan. It is usually considered alongside another cancer treatment.

We will complete a full medical assessment before we determine whether or not thermal therapies will be appropriate for you and your case.

Yes, all our meals are prepared on site. We offer breakfast and lunch as well as snacks and smoothies / shakes at the clinic and will send evening meals home with our patients. Our aim, alongside ensuring nutritious meals that help with recovery, is to remove all minor stresses to enable patients to focus solely on healing. Our keto-based diet is predominantly organic and is also halal.